June 2016 Policy Analysis The Public Health Implications of the FDA Update to the Medication Abortion Label Rachel K. Jones and Heather D. Boonstra
June 2016 Opinion The Public Health Implications of the FDA Update to the Medication Abortion Label Rachel K. Jones and Heather D. Boonstra Health Affairs Blog
June 2016 Infographic Twice as many abortion patients are eligible for medication abortion following the 2016 FDA label change
June 2016 News Release June 2016 Issue of Perspectives on Sexual and Reproductive Health Now Available
June 2016 News Release Guttmacher Institute Announces Third Cory L. Richards Memorial Scholarship Recipient
June 2016 News Release State Innovation Under Health Reform Is Likely to Impact Access to Sexual and Reproductive Health Coverage and Care
